BC
Bhanwarlal Choudhary
About Bhanwarlal Choudhary
Data last updated:
Bhanwarlal Choudhary has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Biorealm Biopharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Biorealm Biopharmaceuticals Private Limited at ₹5.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biorealm Biopharmaceuticals Private Limited U24299MH2013PTC250679 | Director | 03 Dec 2013 | 2013 | ₹5.25 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhanwarlal Choudhary
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhanwarlal Choudhary
Bhanwarlal Choudhary has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Biorealm Biopharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Biorealm Biopharmaceuticals Private Limited at ₹5.25 Cr (FY 2024).
Bhanwarlal Choudhary is associated with 1 company as Director, including Biorealm Biopharmaceuticals Private Limited (₹5.25 Cr).
Bhanwarlal Choudhary has expertise in General Business.
Bhanwarlal Choudhary has 12 years in corporate governance.
By reported revenue, the largest current company of Bhanwarlal Choudhary is Biorealm Biopharmaceuticals Private Limited, with revenue of ₹5.25 Cr (FY 2024).
Bhanwarlal Choudhary currently holds positions at 1 company: Biorealm Biopharmaceuticals Private Limited (₹5.25 Cr).